PARAMETRIC PORTFOLIO ASSOCIATES LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$304,000
-4.1%
150,446
+28.7%
0.00%
Q4 2021$317,000
-26.1%
116,894
+21.5%
0.00%
Q3 2021$429,000
-18.6%
96,220
+5.9%
0.00%
Q2 2021$527,000
-1.5%
90,836
+19.2%
0.00%
Q1 2021$535,000
+159.7%
76,178
+77.3%
0.00%
Q4 2020$206,000
+15.7%
42,975
+40.8%
0.00%
Q3 2020$178,000
-74.0%
30,532
-69.9%
0.00%
-100.0%
Q2 2020$684,000
+208.1%
101,342
+189.8%
0.00%
Q1 2020$222,000
-34.3%
34,966
+7.9%
0.00%
Q4 2019$338,000
-24.6%
32,400
+7.6%
0.00%
Q2 2019$448,000
-73.8%
30,110
-56.3%
0.00%
-100.0%
Q1 2019$1,710,000
+84.3%
68,897
+33.4%
0.00%0.0%
Q4 2018$928,000
-47.0%
51,666
-13.4%
0.00%
-50.0%
Q3 2018$1,752,000
+13.3%
59,653
+75.3%
0.00%
+100.0%
Q2 2018$1,547,000
-18.1%
34,030
-4.8%
0.00%
-50.0%
Q1 2018$1,888,000
-11.4%
35,756
+14.1%
0.00%0.0%
Q4 2017$2,131,000
-45.5%
31,335
-33.9%
0.00%
-50.0%
Q3 2017$3,908,000
-24.1%
47,431
-13.8%
0.00%
-33.3%
Q2 2017$5,152,000
+29.5%
55,026
-11.9%
0.01%0.0%
Q1 2017$3,977,000
+255.1%
62,458
+147.6%
0.01%
+200.0%
Q4 2016$1,120,000
+162.3%
25,221
+113.1%
0.00%
+100.0%
Q3 2016$427,000
+196.5%
11,837
+13.2%
0.00%
Q2 2016$144,000
-36.6%
10,461
+61.0%
0.00%
Q4 2015$227,000
-87.5%
6,498
-67.0%
0.00%
-100.0%
Q3 2015$1,809,000
+17.9%
19,667
+12.6%
0.00%
+33.3%
Q2 2015$1,535,000
+13.0%
17,471
-4.5%
0.00%0.0%
Q1 2015$1,358,000
+16.3%
18,298
-12.3%
0.00%
+50.0%
Q4 2014$1,168,000
+26.4%
20,856
+2.3%
0.00%0.0%
Q3 2014$924,000
+95.8%
20,378
+78.8%
0.00%
+100.0%
Q2 2014$472,000
-63.9%
11,394
-39.7%
0.00%
-66.7%
Q1 2014$1,309,000
+21.7%
18,900
+5.8%
0.00%0.0%
Q4 2013$1,076,000
+63.8%
17,858
+65.2%
0.00%
+50.0%
Q3 2013$657,000
+127.3%
10,808
+150.6%
0.00%
+100.0%
Q2 2013$289,0004,3120.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders